Daniel Kotz
Daniel Kotz
Institute of General Practice Addiction Research and Clinical Epidemiology Unit, Medical Faculty of the Heinrich-Heine-University Düsseldorf
Verified email at - Homepage
Cited by
Cited by
Real‐world effectiveness of e‐cigarettes when used to aid smoking cessation: a cross‐sectional population study
J Brown, E Beard, D Kotz, S Michie, R West
Addiction 109 (9), 1531-1540, 2014
A simple formula for the calculation of sample size in pilot studies
W Viechtbauer, L Smits, D Kotz, L Budé, M Spigt, J Serroyen, R Crutzen
Journal of clinical epidemiology 68 (11), 1375-1379, 2015
Explaining the social gradient in smoking cessation: it’s not in the trying, but in the succeeding
D Kotz, R West
Tobacco control 18 (1), 43-46, 2009
Predictive validity of the Motivation To Stop Scale (MTSS): a single-item measure of motivation to stop smoking
D Kotz, J Brown, R West
Drug and alcohol dependence 128 (1-2), 15-19, 2013
Smoking cessation for people with chronic obstructive pulmonary disease
EAM van Eerd, RM van der Meer, OCP van Schayck, D Kotz
Cochrane Database of Systematic Reviews, 2016
‘Real‐world’effectiveness of smoking cessation treatments: a population study
D Kotz, J Brown, R West
Addiction 109 (3), 491-499, 2014
A mobile app to aid smoking cessation: preliminary evaluation of SmokeFree28
HK Ubhi, S Michie, D Kotz, WC Wong, R West
Journal of medical Internet research 17 (1), e17, 2015
Healthcare financing systems for increasing the use of tobacco dependence treatment
AA Reda, D Kotz, SMAA Evers, CP van Schayck
Cochrane Database of Systematic Reviews, 2012
How effective and cost-effective was the national mass media smoking cessation campaign ‘Stoptober’?
J Brown, D Kotz, S Michie, J Stapleton, M Walmsley, R West
Drug and alcohol dependence 135, 52-58, 2014
Differential attrition in health behaviour change trials: a systematic review and meta-analysis
R Crutzen, W Viechtbauer, M Spigt, D Kotz
Psychology & health 30 (1), 122-134, 2015
IL6 and CRPhaplotypes are associated with COPD risk and systemic inflammation: a case-control study
DG Yanbaeva, MA Dentener, MA Spruit, JJ Houwing-Duistermaat, D Kotz, ...
BMC medical genetics 10, 1-11, 2009
Incidence, prevalence, and trends of general practitioner–recorded diagnosis of peanut allergy in England, 2001 to 2005
D Kotz, CR Simpson, A Sheikh
Journal of Allergy and Clinical Immunology 127 (3), 623-630. e1, 2011
External validation of a COPD diagnostic questionnaire
D Kotz, P Nelemans, CP Van Schayck, GJ Wesseling
European Respiratory Journal 31 (2), 298-303, 2008
The use of tobacco, e-cigarettes, and methods to quit smoking in Germany: A representative study using 6 waves of data over 12 months (the DEBRA study)
D Kotz, M Böckmann, S Kastaun
Deutsches Ärzteblatt International 115 (14), 235, 2018
Reliability and validity of the clinical COPD questionniare and chronic respiratory questionnaire
AA Reda, D Kotz, JWH Kocks, G Wesseling, CP van Schayck
Respiratory medicine 104 (11), 1675-1682, 2010
Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study
D Kotz, W Viechtbauer, C Simpson, OCP van Schayck, R West, A Sheikh
The Lancet Respiratory Medicine 3 (10), 761-768, 2015
Prospective cohort study of the effectiveness of smoking cessation treatments used in the “real world”
D Kotz, J Brown, R West
Mayo Clinic Proceedings 89 (10), 1360-1367, 2014
Factors associated with the use of aids to cessation in English smokers
D Kotz, J Fidler, R West
Addiction 104 (8), 1403-1410, 2009
Moderators of real‐world effectiveness of smoking cessation aids: a population study
SE Jackson, D Kotz, R West, J Brown
Addiction 114 (9), 1627-1638, 2019
Predictors of 1-year mortality at hospital admission for acute exacerbations of chronic obstructive pulmonary disease
RHJ Slenter, RTM Sprooten, D Kotz, G Wesseling, EFM Wouters, ...
Respiration 85 (1), 15-26, 2012
The system can't perform the operation now. Try again later.
Articles 1–20